PMID- 23545832 OWN - NLM STAT- MEDLINE DCOM- 20140905 LR - 20130402 IS - 1672-7347 (Print) IS - 1672-7347 (Linking) VI - 38 IP - 3 DP - 2013 Mar TI - [Visfatin level after laparoscopic Roux-en-Y gastric bypass surgery in patients with Type 2 diabetes]. PG - 258-61 LID - 10.3969/j.issn.1672-7347.2013.03.007 [doi] AB - OBJECTIVE: To investigate the change in serum visfatin level after laparoscopic Roux-en-Y gastric bypass surgery in patients with Type 2 diabetes mellitus (T2DM) and to explore the relationship between visfatin insulin resistance and diabetes. METHODS: Thirty-three patients with Type 2 diabetes were studied before and after the gastric bypass surgery. The level of fasting serum visfatin was measured by enzyme-linked immunosorbent assay. Fasting plasma glucose (FPG), glycated hemoglobin (HbA1c) and fasting insulin (FINS) were measured before and after the gastric bypass surgery. RESULTS: Compared with before the operation, the indicators of HbA1c, FINS, and insulin resistance index (HOMA-IR) were decreased after the laparoscopic Roux-en-Y gastric bypass surgery. The body mass index (BMI) [(24.53 +/- 0.62) kg/m(2) vs (26.71 +/- 0.69) kg/m2] was decreased, with significant difference (P<0.001). The serum visfatin level [(9.79 +/- 0.64) ng/mL] was significantly lower than before the operation [(38.24 +/- 5.32) ng/mL], with significant difference (P<0.001). CONCLUSION: Serum level of visfatin is decreased in T2DM patients who undergo gastric bypass surgry, reflecting an improvement in insulin resistance and diabetes. FAU - Liu, Yiqun AU - Liu Y AD - Department of Endocrinology, Third Xiangya Hospital, Central South University, Changsha 410013, China. easd04mzh@126.com FAU - Xiong, Jing AU - Xiong J FAU - He, Honghui AU - He H FAU - Zhu, Shaihong AU - Zhu S FAU - Mo, Zhaohui AU - Mo Z LA - chi PT - English Abstract PT - Journal Article PL - China TA - Zhong Nan Da Xue Xue Bao Yi Xue Ban JT - Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences JID - 101230586 RN - EC 2.4.2.12 (Nicotinamide Phosphoribosyltransferase) SB - IM MH - Diabetes Mellitus, Type 2/blood/*surgery MH - Female MH - *Gastric Bypass MH - Humans MH - Insulin Resistance MH - *Laparoscopy MH - Male MH - Middle Aged MH - Nicotinamide Phosphoribosyltransferase/*blood MH - Postoperative Period EDAT- 2013/04/03 06:00 MHDA- 2014/09/06 06:00 CRDT- 2013/04/03 06:00 PHST- 2013/04/03 06:00 [entrez] PHST- 2013/04/03 06:00 [pubmed] PHST- 2014/09/06 06:00 [medline] AID - 10.3969/j.issn.1672-7347.2013.03.007 [doi] PST - ppublish SO - Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Mar;38(3):258-61. doi: 10.3969/j.issn.1672-7347.2013.03.007.